15.80
전일 마감가:
$15.22
열려 있는:
$15.44
하루 거래량:
75,009
Relative Volume:
0.44
시가총액:
$575.93M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+3.06%
1개월 성능:
+44.75%
6개월 성능:
+24.90%
1년 성능:
-39.39%
Rapport Therapeutics Inc Stock (RAPP) Company Profile
명칭
Rapport Therapeutics Inc
전화
857-321-8020
주소
1325 BOYLSTON STREET, BOSTON
RAPP을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
RAPP
Rapport Therapeutics Inc
|
15.78 | 511.33M | 0 | 0 | 0 | 0.00 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
467.92 | 123.00B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
551.17 | 59.66B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
322.30 | 41.84B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
569.71 | 33.98B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
288.85 | 27.67B | 3.81B | -644.79M | -669.77M | -6.24 |
Rapport Therapeutics Inc Stock (RAPP) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-04-08 | 개시 | Citizens JMP | Mkt Outperform |
2024-07-02 | 개시 | Jefferies | Buy |
2024-07-02 | 개시 | Stifel | Buy |
2024-07-02 | 개시 | TD Cowen | Buy |
Rapport Therapeutics Inc 주식(RAPP)의 최신 뉴스
JMP reiterates Market Outperform rating on Rapport Therapeutics stock By Investing.com - Investing.com Canada
What makes PTC Therapeutics Inc. stock price move sharplyTop Momentum Stock Pick - Newser
Why CRMD stock attracts strong analyst attentionAlpha Stock Ideas - Newser
Why Rapport Therapeutics Inc. stock attracts strong analyst attentionHigh Return Intraday Picks - Newser
How High Can MOON(moon coin) GoFree Wealth-Building Investment Strategies - Newser
How Rapport Therapeutics Inc. stock performs during market volatilitySmart Money Signals - Newser
Why Entegris Inc. stock attracts strong analyst attentionVerified Return Tips - Newser
Why Coya Therapeutics Inc. stock attracts strong analyst attentionFree Access to Group - Newser
What makes CIGI stock price move sharplyHigh Return Intraday Picks - Newser
What makes Rapport Therapeutics Inc. stock price move sharplyFree Insider Trading Tips - Newser
How American Water Works Company Inc. stock performs during market volatilityChart Breakout Alert - Newser
What makes IPCXU stock price move sharplyFree Group Entry - Newser
When CLEU stock expected to show significant growthIs SXTC stock a good long term investment optionTriple Return With Stability - Newser
Why SPHL stock attracts strong analyst attentionFree Stock Market Strategy Classes - Newser
Leverage AI to enhance your marketing strategy with real time consumer insightsHigh Return Setup Scanner - Newser
Why Did Rapport Therapeutics Plunge 15.68%? Regulatory Setbacks, Financial Strain - AInvest
Rapport Therapeutics’ (RAPP) Market Outperform Rating Reiterated at JMP Securities - Defense World
How will RAPP's Q1 2025 earnings forecast impact investors? - AInvest
Rapport Therapeutics, Inc.(NasdaqGM: RAPP) dropped from Russell Microcap Growth Index - MarketScreener
How To Trade (RAPP) - news.stocktradersdaily.com
GAMMA Investing LLC Purchases 9,198 Shares of Rapport Therapeutics (NASDAQ:RAPP) - Defense World
Bank of America Corp DE Sells 12,532 Shares of Rapport Therapeutics (NASDAQ:RAPP) - Defense World
California State Teachers Retirement System Purchases 7,886 Shares of Rapport Therapeutics (NASDAQ:RAPP) - Defense World
Analysts Can't Get Enough of These Little-Known Biopharma Stocks - Investing.com
Analysts Can't Get Enough of These Little-Known Biopharma Stocks - MarketBeat
(RAPP) Long Term Investment Analysis - news.stocktradersdaily.com
Rapport Therapeutics management to meet with Citizens JMP - TipRanks
Deutsche Bank AG Invests $41,000 in Rapport Therapeutics (NASDAQ:RAPP) - Defense World
Analysts Offer Insights on NA Companies: Tempus AI, Inc. Class A (TEM) and Rapport Therapeutics, Inc. (RAPP) - The Globe and Mail
Stifel reiterates buy rating for Rapport Therapeutics stock By Investing.com - Investing.com Nigeria
Citizens JMP maintains positive outlook on Rapport Therapeutics stock By Investing.com - Investing.com UK
Rapport Therapeutics Completes Enrollment for Phase 2a Trial - TipRanks
Rapport Therapeutics Hosts Investor and Analyst Day; Provides Corporate Updates - GlobeNewswire
Rapport Therapeutics Hosts Inaugural Investor and Analyst Day to Update on RAP-219 and Clinical Pipeline - Nasdaq
How the (RAPP) price action is used to our Advantage - news.stocktradersdaily.com
Rapport Therapeutics to Participate in the Jefferies Global - GlobeNewswire
Rapport Therapeutics (RAPP) to Release Quarterly Earnings on Monday - Defense World
Rapport Therapeutics to Host 2025 Investor and Analyst Day - GlobeNewswire
Companies Like Rapport Therapeutics (NASDAQ:RAPP) Are In A Position To Invest In Growth - Yahoo Finance
Rapport Therapeutics Reports Q1 2025 Financial Results - MSN
Wells Fargo & Company MN Grows Stake in Rapport Therapeutics (NASDAQ:RAPP) - Defense World
Barclays PLC Buys 5,634 Shares of Rapport Therapeutics (NASDAQ:RAPP) - Defense World
Rapport Therapeutics, Inc. SEC 10-Q Report - TradingView
Rapport Therapeutics Reports First Quarter 2025 Financials and Provides Business Update - The Manila Times
(RAPP) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Charles River agrees with Elliott to add new directors, review business - The Mighty 790 KFGO
Rapport Therapeutics (NASDAQ:RAPP) Shares Acquired by JPMorgan Chase & Co. - Defense World
Legal & General Group Plc Buys 8,614 Shares of Rapport Therapeutics (NASDAQ:RAPP) - Defense World
Rapport Therapeutics (NASDAQ:RAPP) Shares Acquired by Geode Capital Management LLC - Defense World
Rapport Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times
Rapport Therapeutics Inc (RAPP) 재무 분석
Rapport Therapeutics Inc (RAPP)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Rapport Therapeutics Inc 주식 (RAPP) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Bredt David | Chief Scientific Officer |
Jun 16 '25 |
Sale |
11.00 |
8,500 |
93,522 |
443,642 |
자본화:
|
볼륨(24시간):